Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. Das A, Tabori U, Sambira Nahum LC, Collins NB, et al. Clin Cancer Res 2023;29:4770-4783.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Das A, Tabori U, Sambira Nahum LC, Collins NB, et al. Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. Clin Cancer Res 2023;29:4770-4783.
PMID: 37126021